Podcasts about kenvue

Brandon Daniels is the CEO at Exiger. In this episode, he joins host Charlie Osborne and David Merritt, Director of Defensive Analytics as Kenvue, to discuss cybersecurity in mainstream media and the value of prioritization, highlighted by Netflix's "Zero Day" series. Exiger is revolutionizing the way corporations, government agencies and banks navigate risk and compliance in their third-parties, supply chains and customers through its software and tech-enabled solutions. To learn more about our sponsor, visit https://exiger.com.

Threat of levies on $107 billion of goods is in case negotiations fail. Plus: U.S. jobless claims fell last week, indicating labor market resilience. Molson Coors reported a drop in first-quarter net income. And Johnson & Johnson spinoff Kenvue saw Q1 earnings growth ahead of expectations. Charlotte Gartenberg hosts. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com AI and data are being used to transform consumer healthcare by personalizing experiences, reducing friction, supporting growth, and promoting sustainable innovation. In this episode of The Beat podcast, Bernardo Tavares, Chief Technology and Data Officer at Kenvue, discusses leveraging AI and data to transform consumer healthcare. He shares his journey from the tech industry to consumer goods and healthcare, emphasizing how technology can enhance the consumer experience. Kenvue, known for brands like Tylenol and Listerine, is the largest pure-play consumer health company and focuses on digital reinvention. Bernardo highlights how AI can personalize consumer interactions, reduce operational friction, and drive growth. He also discusses sustainability efforts, including a digital menopause platform aimed at breaking societal taboos. Tune in to discover how Kenvue is revolutionizing consumer healthcare with AI and data innovation Resources: Connect with and follow Bernardo Tavares on LinkedIn. Follow Kenvue on LinkedIn and Instagram and visit their website.  Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

In this second episode of a three-part series, Drs. Ruth Carrico and Paula Tucker explore the challenges of medical misinformation, its impact on patient care and strategies for navigating the overwhelming flow of health information in today's digital age. The discussion covers the rise of the "infodemic” how misinformation spreads and how nurse practitioners (NPs) can critically evaluate medical literature to ensure evidence-based practice. The hosts share real-world experiences from the COVID-19 pandemic, highlighting the difficulties of adapting to rapidly evolving guidelines while maintaining public trust. They also discuss the role of social determinants of health in the spread of misinformation and provide practical solutions for mitigating misinformation in clinical settings. Key Takeaways: Understanding the Infodemic: Definition: An overload of health-related information — both accurate and inaccurate — spread rapidly via social media, news and professional circles. Impact of COVID-19: Misinformation amplified due to evolving scientific knowledge, political influences and social media algorithms. Role of Trust: Public mistrust in health care institutions and shifting guidelines fueled skepticism. Misinformation Drivers and Consequences: Psychological Factors: Cognitive biases (confirmation bias, authority bias) make individuals more susceptible to misinformation. Technology and Social Media: Algorithm-driven content creates echo chambers where misinformation spreads unchecked. Public Health Outcomes: Misinformation leads to vaccine hesitancy, delayed treatments and preventable deaths. How NPs Can Combat Misinformation: 1. Active Listening: Understand patients' concerns before correcting misinformation. 2. Effective Communication: Use simple, culturally relevant messaging tailored to health literacy levels. 3. Building Resilience: Teach patients how to critically evaluate health information sources. 4. Community Engagement: Collaborate with local leaders and organizations to promote credible information. Evaluating Evidence-Based Information: Use the CRAAP Test (Currency, Relevance, Authority, Accuracy, Purpose) to assess credibility. Trust peer-reviewed sources like CDC, WHO, FDA, Cochrane Reviews and PubMed. Be aware of misleading studies and cherry-picked data used to spread misinformation. Trusted Resources for Patients and Providers: For Clinicians: UpToDate, DynaMed, BMJ Best Practice, Cochrane Reviews. For Patients: MedlinePlus, Mayo Clinic, CDC Vaccine Fact Sheets, American Heart Association. To claim 1.1 contact hours (CH) of continuing education (CE) credit for this program, “Navigating the Infodemic: A Call for Critical Thinking to Optimize Patient Care,” search for this program by the title and complete the posttest and evaluation by entering the participation code provided after listening to the podcast. “This activity is sponsored by an independent medical education grant from Kenvue.” Tool: https://www.aanp.org/practice/clinical-resources-for-nps/clinical-resources-by-therapeutic-area/primary-care Next Episode Preview: In the final episode of this series, Drs. Carrico and Tucker will dive into practical strategies for debunking medical myths, patient-centered communication techniques and choosing the right battles when addressing misinformation.

Chuck Zodda and Mike Armstrong discuss the comments from JPMorgan CEO, Jaime Dimon, about the considerable turbulence the economy is facing. There have been some famous examples of strange recession indicators over the years. Stubbornly high mortgage rates might crush the spring home-buying season. Paul LaMonica, Barron's, joins the show to chat about Kenvue and what some analysts are saying about the company.

If you're a strategy leader stepping into M&A or refining your inorganic growth strategy, there's one relationship that can either propel you forward or hold you back: your relationship with investment bankers. In this episode, we dive deep into the often opaque world of investment banking with two strategy executives who've worked across both sides of the deal table.    Together, our guests bring more than 40 years of combined experience across investment banking, M&A strategy, and corporate development—having led acquisitions and divestitures in both public and private companies, across industries and borders.  Michael Arlotto is the Global Head of Corporate Development and Ventures at Kenvue, an American consumer health company and the proprietor of many brands you've heard of, like Band-Aid, Benadryl, Neutrogena and Tylenol.  Chris Nuttall is the Executive Vice President of Corporate Development at Bazaarvoice, an American tech company that helps brands collect and leverage UGC, which stands for user-generated content. Together, the three of us explore:- How to assess and build the right relationship with an investment banker  - What “transformative M&A” really means—and how to pull it off  - The soft skills and cultural fit that matter just as much as deal terms  - How to avoid M&A regret by starting with strategy and ending with integration  - Why successful M&A is less about buying a company—and more about buying into a multiyear business plan    Whether you're planning your first acquisition or fine-tuning your approach to external growth, this episode will help you build stronger partnerships, avoid costly missteps, and execute deals that deliver long-term value.Learn more about Outthinker's community of chief strategy officers - https://outthinkernetwork.com/Follow us on LinkedIn - https://www.linkedin.com/company/outthinker-networksLearn more about Outthinker's community of chief strategy officers - https://outthinkernetwork.com/Follow us on LinkedIn - https://www.linkedin.com/company/outthinker-networksLearn more about Outthinker's community of chief strategy officers - https://outthinkernetwork.com/Follow us on LinkedIn - https://www.linkedin.com/company/outthinker-networks Learn more about Outthinker's community of chief strategy officers - https://outthinkernetwork.com/ Follow us on LinkedIn - https://www.linkedin.com/company/outthinker-networks

With the S&P 500 and Nasdaq snapping four-week losing streaks on Friday, David Faber and Jim Cramer explored Monday's market rally, sparked by reports President Trump will narrow tariffs set to be announced April 2. Tesla among the biggest gainers as the stock looks to avoid a ten-week losing streak. The anchors discussed AI-related developments on the heels of last week's Cramer interview with Nvidia CEO Jensen Huang. Also in focus: Chinese officials court Apple's Tim Cook and other CEOs at a development forum in Beijing, M&A deals, hedge fund pushes for a sale of Johnson & Johnson spin-off Kenvue.  Squawk on the Street Disclaimer

In this first of three podcasts on medical misinformation titled, "Wash Your Hands!: Discerning Facts from the Preposterous vs. Plausible," NP experts Paula Tucker and Ruth Carrico focus on the critical issue of medical misinformation in the United States and its widespread impact. The content aims to help listeners identify medical information they've accepted without credible evidence and apply critical thinking to determine the validity of commonly accepted medical claims. This episode explores the role of biases, health care disparities and social determinants of health in perpetuating misinformation. It emphasizes the importance of asking the right questions, seeking reliable data and recognizing the hallmarks of unfounded health claims. The accompanying educational resource, "A Clinician's Guide to Medical Misinformation – Part 1: Discernment," provides a comprehensive review of misinformation hallmarks, common tactics and real-world clinical scenarios to help health care professionals and patients navigate the complex landscape of health information. Learning Objectives: Identify at least one piece of medical information you have accepted without credible evidence of validity. Apply critical thinking to determine the validity of commonly accepted medical information. To claim 1.0 contact hours (CH) of continuing education (CE) credit for this program, "Wash Your Hands! Discerning Facts from the Preposterous vs. Plausible," click here to go to the AANP CE Center and complete the post-test and evaluation by entering the participation code provided after listening to the podcast. Download the clinical resource here. This podcast and resource tool were supported by an independent medical education grant from Kenvue. 

With the S&P 500 on track for its worst week since September, Carl Quintanilla, Jim Cramer and David Faber explored this week's market sell-off, as well as comments from Commerce Secretary Lutnick. He said to expect a Wednesday announcement from President Trump on Canada and Mexico tariffs. Jim highlighted what's at stake for U.S. automakers. Also in focus: President Trump calls for passing tax cuts and killing the CHIPS Act in his Tuesday night address to Congress, more sales woes for Tesla, "Faber Report" on Kenvue's proxy fight, earnings pain for retailers, CrowdStrike and Campbell's slide, the New York Financial Writers' Association honors David. Squawk on the Street Disclaimer

In this episode, Host Paul Barnhurst, aka The FP&A Guy, explores the complexities of corporate spin-offs with guest Jens Gutberlet. They focus on Kenvue's remarkable journey of separating from Johnson & Johnson with strategic reasoning and organizational transformation. This discussion highlights the challenges and opportunities that arise when creating a standalone company from a global giant.Jens Gutberlet is a seasoned finance leader with over 15 years of experience in multinational consumer goods companies like Henkel, Edgewell, Johnson & Johnson, and now Kenvue. Based in Toronto, Jens has spearheaded major transformation projects, including two large-scale company separations. His expertise in FP&A and organizational change shines through as he shares his insights from Kenvue's historic spin-off.Expect to Learn:Why Johnson & Johnson decided to spin off Kenvue and the strategic benefits of the separation.The key challenges and milestones in creating a new standalone company.How FP&A professionals can contribute to major transformation projects.The importance of mindset and communication during organizational change.Opportunities for improvement in finance systems and processes during spin-offs.Here are a few relevant quotes from the episode:"Understanding the 'why' behind a transformation is crucial for keeping people engaged and motivated." - Jens Gutberlet"Managing cultural and people aspects during transformation is often harder than tackling technology." - Jens Gutberlet"The key to success is breaking down massive projects into manageable, bite-sized steps." - Jens GutberletJens emphasizes the importance of communication, strategic thinking, and adaptability in navigating the complexities of organizational change. For FP&A professionals, spin-offs are a unique opportunity to shape the future of a company and build robust financial systems.World-class Digital FP&A Course Bundle: Signup for over ten hours of video content with 4 different courses and 8 modules on FP&A topics including: Business Partnering, Data Analysis, Financial Modeling Design Principles, and Modern Excel. Use code Podcast to save 25%. What are you waiting for signup now: https://bit.ly/4decOf3Follow FP&A Tomorrow:Newsletter - Subscribe on LinkedIn - https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=6957679529595162624 Follow Jens:LinkedIn - https://www.linkedin.com/in/jens-gutberlet/Follow Paul: Website - https://www.thefpandaguy.com LinkedIn - https://www.linkedin.com/in/thefpandaguyEnroll for Wharton Online Certificate Program:Sign up for the 8 week online financial planning & analysis certificate program by Wharton Online and learn the art of forecasting, analysis, business partnering and financial storytelling: https://bit.ly/4debs46 Use Code: THEFPAGUY300 to save $300. Earn Your CPE Credit...

Happy New Year!  We kick off 2025 with Neha Shah, Senior Manager, Digital Commerce and Omnichannel Shopper Marketing at The Campbell's Company.  Neha's nearly two-decade career has included senior eCommerce positions at Johnson & Johnson and Kenvue.  In her new role, she is spearheading omnichannel efforts across the Campbell's portfolio of brands.     Neha shares her experiences in the early days of eCommerce (7:47), the evolution of the consumer journey in recent years (10:58), navigating Amazon AVN negotiations (13:12), how Campbell's is pioneering the next wave of what's happening in the omni and retail media spaces (19:36), and her favorite books on personal and professional development (22:41). Note: all views expressed in this episode are Neha's personal POV.Connect with Neha: https://www.linkedin.com/in/msnehashah/Take advantage of a special offer from It'sRapid and get a free image, video or banner ad by emailing sales@itsrapid.io with code "BEYOND2024"Learn more about ItsRapid: https://itsrapid.ai/ Theme music: "Happy" by Mixaud - https://mixaund.bandcamp.comProducer: Jake Musiker

We're thrilled to bring you the third annual Year End Special of the Courageous Podcast! This year, Ryan is once again joined by his partners at Courageous representing the three pillars of Courage: Knowledge (Billy Collins), Faith (Ryan), and Action (Nicole Miller). But the fun doesn't stop there—this episode features three mystery guests — a mentor, a sports legend, and a Fortune 500 Kenvue executive — who each bring their unique perspectives and surprises to the conversation. Along the way, they reflect on some of the most memorable moments and impactful conversations from Ryan's year on the podcast, tying it all together with wit, wisdom, and humor.

About Bernardo Tavares:Bernardo Tavares is the Chief Technology & Data Officer for Kenvue, where he oversees the Information Technology and Data Science groups. As a key enabler of innovation and growth, he leads the data and technology agenda by scaling digital capabilities to better serve customers and consumers.With extensive experience in business technology life-cycle management and value creation, IT transformation and optimization, Bernardo has worked across consumer, healthcare, and technology industries. His expertise spans sales, digital marketing and analytics, strategic and solutions architecture, organization design and management, IT governance and risk management, program and portfolio optimization, application services, business analysis, and talent development.Passionate about commercial innovation, digital transformation, precision marketing, and digital solution development, Bernardo believes that technology, science, data, and design can unlock value for customers while improving sustainability, health, and well-being for the communities served by Kenvue.Things You'll Learn:AI and data are being leveraged to personalize consumer experiences, reduce operational friction, and support growth in the healthcare sector.Maintaining privacy and building trust with consumers is crucial for the successful implementation of AI and data-driven solutions.Kenvue is committed to sustainability, ensuring clean data and innovation that aligns with its ESG goals.Kenvue has launched a digital menopause platform designed to break societal taboos and provide comprehensive care.A mindset of continuous learning, trust, and curiosity would responsibly harness the power of technology and drive innovation.Resources:Connect with and follow Bernardo Tavares on LinkedIn.Follow Kenvue on LinkedIn and Instagram and visit their website. 

summaryIn this episode, Sarah Nagle and Chad Reynolds discuss the evolution of AI and its application in various industries, focusing on the concept of expert agents. They explore how these agents can enhance innovation processes within organizations, featuring insights from industry leaders and examples of expert agents like Sawyer, a universal design expert, and Dr. Samantha, a dermatologist. The conversation highlights the importance of collaboration and the potential of AI to democratize access to expertise. In this conversation, Sarah Nagle interviews Kathy Rutherford about her role at Kenview and how she has integrated AI into the innovation process. Kathy shares insights on the impact of AI on market research, the importance of anchoring AI to existing processes, and how it has changed team dynamics and creativity. The discussion also covers the future of consumer insights and the challenges of adopting AI in organizations, concluding with Kathy's advice for others looking to integrate AI into their processes.Chapters00:00Introduction to AI and Creativity04:27Exploring Expert Agents in Organizations20:48The Role of Expert Agents in Innovation29:46Meet the Expert Agents: Sawyer and Dr. Samantha34:59Integrating AI into Innovation Processes35:28Kathy Rutherford's Role and Background36:53The Impact of AI on Market Research39:14Introducing AI to Teams42:11Enhancing Creativity with AI Agents47:52Behavioral Changes in Teams50:16The Future of AI in Organizations52:40Overcoming Challenges in AI Adoption55:00Moments of Realization58:42The Future of Consumer Insights01:01:03Consumer Expectations and Innovation01:03:51Advice for Integrating AIEventshttps://www.eventbrite.com/e/co-creating-the-future-with-ai-tickets-1084864491899?aff=oddtdtcreatorVurvey.com

Heute bei Aktien fürs Leben:Wochenrückblick: NVIDIA liefert richtig tolle Zahlen ab, doch die Erwartungen sind immer noch hoch (1:39) / Amazon investiert im Wettrennen gegen Microsoft in das KI-Startup Anthropic (5:27) / Donald Trumps designierter US-Finanzminister, Hedgefonds-Manager Scott Bessent, hat hohe Ziele (7:32) /Wahre Größe: Wie läuft das Geschäft von Kenvue, dem Konsumgüter-„Spin off“ von Johnson & Johnson, nach nur 18 Monaten - kommt die Abspaltung bei den Konsument:innen gut an? (10:38) /The trend is your friend: Was macht den dänischen Schmuckhersteller Pandora so attraktiv? (17:27) /Klein, aber oho: Fintech-Refinanzierer SoFi Technologies – ist die Wachstums-Story auch eine Erfolgs-Story? Welche Rolle könnte hier noch eine künftige US-Regierung unter Trump spielen? (23:55) //Um folgende Aktien geht es: Kenvue (WKN: KENV01), Pandora (WKN: A1C6JV), SoFi Technologies (WKN: A2QPMG), NVIDIA (WKN: 918422), Amazon (WKN: 906866) Microsoft (WKN: 870747) +++Keine Anlageberatung oder -empfehlung. Alle Angaben ohne Gewähr, diese stellen keinen Ersatz für eine professionelle und individuelle Beratung dar. Wertentwicklungen der Vergangenheit sind kein Indikator für zukünftige Wertentwicklung. +++Weitere Infos zu unseren Werbepartnern finden Sie hier: https://linktr.ee/aktienfuersleben +++60 Tage lang kostenlos Capital+ lesen - Zugriff auf alle digitalen Artikel, Inhalte aus dem Heft und das ePaper. Unter Capital.de/plus-gratis +++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://datenschutz.ad-alliance.de/podcast.html +++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://art19.com/privacy. Die Datenschutzrichtlinien für Kalifornien sind unter https://art19.com/privacy#do-not-sell-my-info abrufbar.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, following its $1 billion stake in Pfizer. In other news, the FDA has rejected Camurus' treatment for a rare hormonal disorder due to manufacturing issues, while Lilly is ramping up legal action against tirzepatide copycats. Trilink Biotechnologies has introduced custom sets of mRNA for screening studies, offering flexibility and expedited discovery work. Additionally, the FDA has approved Astellas' first-in-class gastric cancer treatment. Pfizer has also announced layoffs in Kansas, and Nucleus, a radiopharma-focused CDMO, is expanding with new plants. These developments reflect the dynamic landscape of the pharmaceutical industry.

Carl Quintanilla, Jim Cramer and David Faber explored market reaction to a slew of earnings reports, including results from Verizon, 3M, GE Aerospace and General Motors.In a CNBC Exclusive, David interviewed Starboard Value CEO Jeff Smith at the 13D Monitor Active-Passive Investor Summit. They discussed the activist investor's push for changes at Pfizer and Kenvue. With Election Day just two weeks away, The anchors reacted to what legendary investor Paul Tudor Jones andBlackRock CEO Larry Fink are saying about the race for the White House. Also in focus: Apple-Nvidia market cap battle. Squawk on the Street Disclaimer

Ohne Aktien-Zugang ist's schwer? Starte jetzt bei unserem Partner Scalable Capital. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Gold schafft das Triple. Trennung oder doch nicht? Das fragen sich Disney, Cigna & Humana. Die Reimann-Familie fragt sich, wie viel Geld sie noch in Kaffee pumpen muss. Spirit Airlines muss sein Geld länger als gedacht nicht zurückpumpen. Aktivist bei Kenvue. SAP, Zoom, Amazon. Alle schicken ihre Mitarbeiter zurück ins Büro. Takkt (WKN: 744600) könnte profitieren. Amazon, Google & Co. pumpen Geld in kleine Atomkraft. Wer profitiert? Oklo (WKN: A3CUTU) & NuScale Power (WKN: A3DK09) sind risky Highflyer. Rolls-Royce (WKN: A1H81L) & Mitsubishi Heavy Industries (WKN: 853314) sind stabile Mitschwimmer. Diesen Podcast vom 22.10.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Plus: Boeing and its machinists union reach a deal, now its members must vote on it. And, activist investor Starboard targets Tylenol maker Kenvue. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Billionaire investor Mark Cuban hit the campaign trail for Vice President Kamala Harris this weekend in battleground states Arizona and Michigan, while fellow billionaire Elon Musk campaigned for former President Donald Trump in Pennsylvania. Cuban discusses why he's supporting Harris, why he finds Donald Trump's tariff plans to be “insane,” and explains that he'll continue speaking his politics in spite of name calling on social media. Plus, Starboard Value has amassed a significant stake in Kenvue, consumer products brand formerly owned by Johnson & Johnson, and Disney announced a plan for chairman and for Bob Iger's  CEO successor reveal. Mark Cuban: 4:10Alex Sherman: 30:23 In this episode:Mark Cuban, @mcubanBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinZach Vallese, @zachvallese

Carl Quintanilla, Jim Cramer and David Faber discussed the markets' record run and six-week win streak as earnings season heats up: Results from the likes of Tesla, Coca-Cola, Verizon and General Motors due out this week. Shares of Boeing jumped after the jet maker and its machinists union reached a tentative agreement that could end a five-week strike. Lots of activism investor developments surrounding Johnson & Johnson spin-off Kenvue, Southwest and CVS Health. Also in focus: Former Morgan Stanley CEO James Gorman to replace Mark Parker as Disney's Chairman in January, all things Apple -- from street analyst calls to what CEO Tim Cook told The Wall Street Journal about Apple Intelligence.    Squawk on the Street Disclaimer 

Carl Quintanilla, Leslie Picker and David Faber discussed the market rally alongside Goldman's new call for slowing growth on the S&P – plus a slew of activist news at Southwest and consumer goods giant Kenvue. Also in focus: Disney's succession news, a potential labor deal at Boeing, and a deep dive into one swing state county less than 2 weeks from the election. Squawk on the Street Disclaimer

Andrew, Ben, and Tom discuss this weekend's college football games, Starboard Value taking a stake in Kenvue, and the week ahead. For information on how to join the Zoom calls live each morning at 8:30 EST, visithttps://www.narwhalcapital.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhalcapital.com/disclosure

US futures are pointing to a lower open, while European equity markets are mixed. Asian equities also closed with varied results today. In focus today are developments from China, where the People's Bank of China cut the 1-year and 5-year loan prime rates by 25 basis points—slightly more than consensus expectations. PBOC Governor Pan indicated the possibility of reducing the reserve requirement ratio by 25 to 50 basis points by year-end. This comes amid mixed reactions to recent Chinese stimulus efforts, but hopes for more fiscal support remain strong as President Xi pushes for achieving 2024 economic goals.Companies Mentioned: Boeing, Thales, MetLife, Kenvue

The Wall Street Journal reported that Starboard Value has taken a "sizeable" stake in Kenvue (KVUE) with hopes of matching the company's stock price to competitors. Despite having Tylenol and Band-Aid as part of its brand portfolio, George Tsilis looks at the headwinds facing Kenvue's growth. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

It's that time again: earnings season. Q3 calls started out with a bit of a snore from J&J, which did beat analyst expectations but announced no big shakeups or surprises. As expected, the company saw shrinking revenue for its blockbuster Stelara, which just lost to Lilly's Omvoh in a head-to-head clinical trial in Crohn's disease. Last week, a concerning study was published regarding seven children who developed blood cancers after being treated with bluebird bio's gene therapy Skysona. This publication comes at a time when the company is struggling to regain its share price, which has dropped below the Nasdaq minimum bid price requirement. The bad news about Skysona also fits with another trend BioSpace covered this week: accelerated approvals gone wrong. In other news, Sanofi is following some of its pharma peers and looking to sell its consumer healthcare unit. This follows similar moves from J&J, which spun off Kenvue last year, as well as GSK, Pfizer and others. And Senator Elizabeth Warren (Mass.-D) is upping the pressure on Novo in relation to its acquisition of Catalent, penning a letter to the Federal Trade Commission voicing concerns about the potential effects of such a deal, should it go through. Finally, bispecific antibodies make a comeback in oncology.

Welcome to another episode of The Ecommerce Braintrust podcast hosted by Acadia's Head of Retail Marketplaces Services Julie Spear and Director of Retail Operations, Jordan Ripley. Today we're joined by Neha Shah, who most recently oversaw the eCommerce Organic Acceleration team at Kenvue and is now a free agent. Before that, Neha spent 17 years at Johnson & Johnson as a Senior Manager overseeing Omnichannel Excellence and Shopper Marketing.  This episode is all about the role of organic marketing in sustainable brand growth - both on Amazon and across other retail channels.  Make sure you tune in to find out more!   Disclaimer: Neha's viewpoints in this podcast episode are separate from her work at Kenvue. These represent her personal opinions and beliefs on the industry.   KEY TAKEAWAYS In this episode, Julie, Neha, and Jordan discuss: The Role of Organic Marketing Organic marketing's often overlooked potential in driving sustainable brand growth. Importance of organic growth in providing cost efficiencies and building brand trust and equity. The common oversight of organic efforts due to the immediate results offered by paid advertising. Organic growth as a long-term strategy that complements paid efforts. Strategies and activities for organic growth, such as keyword and content optimization. Measuring organic success through metrics like revenue, share, average order value, traffic conversion, and organic search rank. The need for a cross-functional team including paid, organic, and shopper leads. Importance of collaboration and adaptability within the team. Leveraging both internal and external resources for technology and data insights. Future Trends to Watch: Rise of social commerce and new marketplaces. Evolution of omnichannel strategies. Impact of AI in areas ranging from content to supply chain operations. What's Next for Neha Shah

O presidente da Kenvue Brasil, Ricardo Wolff, concedeu entrevista ao repórter do Poder360 Houldine Nascimento em 19 de agosto de 2024. A entrevista foi realizada por videoconferência.Alguns produtos não tiveram acesso a um regime diferenciado no texto aprovado na Câmara dos Deputados que regulamenta a reforma tributária sobre o consumo. Foi o caso do protetor solar, que terá a incidência da alíquota padrão do IVA (Imposto sobre Valor Agregado) dual, hoje estimada pelo Ministério da Fazenda em quase 28%.Depois da votação na Casa, a proposta seguiu para o Senado. O presidente da Kenvue Brasil, Ricardo Wolff, diz que o produto ficará mais caro para o consumidor, se o Congresso não reduzir a alíquota sobre o filtro solar.“A nossa marca, Sundown, por exemplo: hoje o consumidor vai ao ponto de venda e consegue encontrar o produto por R$ 50. Se seguir do jeito que está, vão ser provavelmente R$ 5 a mais que essa pessoa vai ter que pagar pelo protetor”, declara em entrevista ao Poder360.

The macro picture might be putting a damper on guidance for some companies, but depressed valuations and climbing cash balances mean as the macro picture clears up, money could come back into the market in waves. (00:21) Jason Moser and Matt Argersinger discuss: - What Brian Niccol will need to do to turn around Starbucks as CEO, and how Chipotle will handle the departure of their superstar executive. - Earnings updates from Home Depot, Walmart, and Brinker. - Warren Buffett's latest buys – Ulta Beauty and Heico – and what Berkshire and other smart money's rising cash hoards might mean. (30:45) Jason and Matt break down two stocks on their radar: Palo Alto Networks and Kenvue. Stocks discussed: SBUX, CMG, HD, WMT, EAT, PANW, KVUE Host: Dylan Lewis Guests: Jason Moser, Matt Argersinger Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Join Michelle Martin's tour of markets. With Ryan Huang, Michelle explores Asia-Pacific markets; trading looks mixed at the morning start as Tokyo, Sydney, and Seoul show varied performances. Corporate earnings are back in focus with significant results from Dyna-Mac, Riverstone, Fraser and Neave, and more. We also delve into the latest from Yum Brands, Uber, and Kenvue. Lastly, the episode covers Elon Musk's legal battle with advertisers.See omnystudio.com/listener for privacy information.

Enjoy a new ADHA24 Podversations episode with quick 10-minute audio snapshots from the exhibit hall with guests Nicole Stout, RDH, Crest + Oral-B Hygienist Proud student award winner; Andrea Johnson, RDH, MS, from Crest + Oral-B; Whitney Howerton, MDH, RDH, CDIPC, from PDT; and Dr. Anu Bharadwaj, DMD, from Kenvue. Hear about the latest and greatest on the exhibit floor, and what attendees are enjoying at ADHA and in New Orleans!    

Ma réaction suite à la chute des actions de Nike. Découvrez une nouvelle position que je rajoute à mon portefeuille. La différence entre le S&P 500 et le S&P500 Equal Weight. Trouver des opportunités d'achat dans un contexte où les indices boursiers sont à des sommets records. CORRECTION: Le segment des produits de consommation de base de Johnson&Johnson a été séparé dans une autre entreprise à part, nommée Kenvue, Inc. (KVUE). L'action de Johnson&Johnson (JNJ) ne concerne que les médicaments. Lien vers l'indice S&P500 Equal Weight: https://www.spglobal.com/spdji/en/indices/equity/sp-500-equal-weight-index/#overview Devenez un insider de la firme Traders 360: ⁠https://traders360.ca/product/infolettre-analyse-360/⁠ Suivez-moi sur Instagram & TikTok IG: alextraders360 TikTok: alexdemers360

This week on the Creator Economy Live Podcast, we have an exciting episode featuring Brendan and Keith, with a special guest appearance by Matt Fantazier, who runs Integrated Media at Kenvue. For those unfamiliar, Kenvue is the new consumer business spun off from Johnson & Johnson, and it includes household brands like Neutrogena, Tylenol, and Listerine.  Matt shares his journey through the major transition from J&J to Kenvue, his experiences in integrated media, and the evolving role of creators in today's brand ecosystems. Discover how influencer marketing has shifted from mere explanations to becoming a crucial part of brand strategies.  Before we dive into our conversation with Matt, Brendan and Keith break down the top stories in the industry, including Meta's NewFronts push, TikTok's premium ad options, and the significant rise in CTV advertising.  

This weeks' episode features the pre-recorded pre-show run of the Sustainability in Cosmetics panel I moderated at NYSCC Suppliers Day in new york a few weeks ago! In conversation with Amol Kirtikar, Senior Manager of Sustainability & Innovation Americas at Clariant, Kurt Reynertson PhD, Global Lead for Ingredient Policy at Kenvue and Akemi Ooka PhD, Head of Global Supply Chain and Sustainability Resources at Independent Beauty Association - the main topic of the panel was around how sustainability misinformation is impacting  the cosmetics sector's ability to pursue sustainable development, and steps moving forward. This conversation was made possible by Clariant, who are the sponsors for this podcast episode.

To celebrate Asian American and Pacific Islander Heritage Month while acknowledging that May is also Mental Health Awareness Month, the SWE Asian Connections Affinity Group shines a light on mental health stigmas in Asian cultures in this episode. Vandana Khanna, head of global digital finance transformation at Kenvue, shares her personal experiences and discusses how companies can better promote mental health awareness. Dr. Katherine Nguyen Williams, clinical professor of psychiatry at the University of California, San Diego and supervising psychologist at Rady Children's Hospital-San Diego, discusses the cultural nuances she has encountered in addressing mental health within the Asian community. Sarah Koenig, associate director for manufacturing cost modeling at Pratt & Whitney, a division of RTX, moderates this important conversation.

Strategic sourcing é uma técnica crucial na gestão de compras que começa com uma análise profunda dos gastos da empresa, seguida por uma avaliação detalhada do mercado para identificar fornecedores, tendências e tecnologias emergentes.Este processo permite desenvolver estratégias de compras focadas, envolvendo a seleção cuidadosa de fornecedores que ofereçam não apenas bons preços, mas também estabilidade e inovação, e a realização de negociações estratégicas que beneficiem ambas as partes.Após a implementação das estratégias, é essencial o monitoramento contínuo do desempenho dos fornecedores e a eficácia das estratégias para garantir ajustes eficientes e manter o processo de compras como um centro de valor estratégico para a empresa. Esse monitoramento assegura que as práticas de strategic sourcing mantenham sua relevância e eficiência ao longo do tempo.Ruy do Café com Comprador, teve o prazer de conversar com Susean Alves, Procurement Category Lead LATAM na Kenvue.Susean compartilhou conosco insights valiosos sobre como o strategic sourcing tem sido aplicado em sua carreira para maximizar o valor das compras e fortalecer as relações com fornecedores, reforçando a importância deste processo nas operações globais das empresas.

Leah Chandler has served as chief marketing officer of Discover Puerto Rico since 2018, and in that time, she's been busy. Chandler has reworked the island's agency relationships into a collective of firms and developed a wide-ranging crisis-response plan for everything from hurricanes to shark bites. She joins the latest edition of The PR Week podcast to talk about that, as well as the biggest marketing and communications news of the week, such as major people moves at Kenvue and Generate:Biomedicines and fresh developments in nationwide student protests and AI.  Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

This Day in Legal History: First Union FormedOn May 1, 1794, a pivotal development in labor rights history occurred in Philadelphia with the formation of the Federal Society of Journeymen Cordwainers. This organization, consisting of skilled shoemakers, marks the establishment of the first trade union in the United States. The union was created as a response to the increasingly difficult economic conditions that tradesmen faced, including low wages and long working hours.The Cordwainers, recognizing the strength in numbers, aimed to leverage their collective bargaining power to negotiate better wages and working conditions. This was a significant step forward in the labor movement, as it introduced the concept of organized labor in America. The formation of this union was not just about improving pay; it was also about dignifying the labor force and providing workers a platform to voice their concerns.Philadelphia, being a hub of commerce and trade in the late 18th century, provided the perfect setting for such an organization. The city's workshops and bustling markets meant that there was a significant demand for skilled labor, which the Cordwainers could supply. However, with industrialization beginning to take root, these skilled workers found themselves under threat from cheaper, mass-produced goods.The Federal Society of Journeymen Cordwainers set a precedent that would be followed by other trades across the country. Their actions led to the establishment of similar societies and unions, which eventually contributed to the broader national labor movement. The Cordwainers themselves faced legal challenges, particularly in 1806, when they were involved in a landmark legal case concerning the rights of workers to organize, known as Commonwealth v. Pullis. In this case, the court ruled against the union, marking one of the first legal battles over the legitimacy of trade union activities in the United States.Despite the legal setbacks, the resilience and pioneering spirit of the Federal Society of Journeymen Cordwainers inspired subsequent generations of workers to fight for their rights. Their legacy is a testament to the enduring struggle for fair labor practices and workers' rights. This day in legal history not only marks the formation of America's first trade union but also celebrates the long journey towards justice and equity in the workplace.The US Patent and Trademark Office (PTO) recently proposed a rule that would require pharmaceutical companies to submit unredacted settlement agreements involving patent challenges to a new repository. This rule is aimed to assist the Federal Trade Commission (FTC) and the Department of Justice (DOJ) in detecting antitrust violations. The proposal arose from concerns that these settlements, often reached in administrative tribunals like the Patent Trial and Appeal Board (PTAB), could be used to delay cheaper biosimilar drugs from entering the market.Evan Diamond, special counsel, noted that the PTO has not clearly defined "good cause" for accessing these agreements, which might increase third-party access and create confidentiality concerns. The fear is that the database could enable federal agencies to easily assess the frequency of potentially anticompetitive pay-for-delay settlements—a practice scrutinized under the Supreme Court's 2013 decision in FTC v. Actavis, which ruled such deals could be illegal.The proposal aligns with an executive order from President Joe Biden encouraging interagency cooperation to prevent practices that unjustifiably delay generic and biosimilar competition. This move has heightened the pharmaceutical industry's fears of increased antitrust enforcement, particularly as the FTC has been actively challenging questionable patent listings that could hinder the approval of generic drugs.Agencies like the FTC and DOJ already have certain reporting requirements under the Medicare Modernization Act for pharmaceutical companies, but the PTO's rule could capture additional agreements that do not meet existing criteria. This has sparked debate over the necessity and potential overlap of the new rule.The pharmaceutical industry, represented by major lobbyist groups like Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization, has expressed strong opposition, citing concerns over the scope of PTO's authority and the ambiguity around the "good cause" criterion.This development highlights a broader regulatory push against anti-competitive practices not only in pharmaceuticals but also in other sectors like technology, where companies like Apple and Google are frequently involved in patent litigation.In summary, the PTO's proposed rule could significantly impact how pharmaceutical settlements are handled, potentially exposing companies to greater antitrust scrutiny. This measure reflects a governmental shift towards stricter oversight of patent practices to foster competition and reduce drug prices.Drug Makers Exposed to Antitrust Probes if Patent Cache AdoptedThis term, Jones Day had the highest number of attorneys—five in total—arguing cases at the U.S. Supreme Court, more than any other firm. Among them, John Gore and C. Kevin Marshall presented for the first time at the high court. Other experienced attorneys like former U.S. Solicitor General Noel Francisco, and partners Hashim Mooppan and Traci Lovitt also argued cases, contributing to the firm's visibility.In comparison, other leading law firms such as Gibson Dunn, Hogan Lovells, and Williams & Connolly had slightly fewer representatives. Gibson Dunn introduced three new attorneys to the Supreme Court lectern, including Theane Evangelis, D. Nick Harper, and Eugene Scalia, who is a son of the late Justice Antonin Scalia. Hogan Lovells' Jessica Ellsworth argued for the first time, including in a significant case regarding the abortion drug mifepristone. Williams & Connolly had Lisa Blatt argue all four of their cases, marking her 50th Supreme Court appearance.Overall, the season saw a mix of seasoned veterans and newcomers. Of the total 152 arguments made, over half were by attorneys who had appeared at least five times before, while a quarter were by first-time arguers. This highlights both the depth of experience and the ongoing introduction of new talent in the legal field's highest echelons.Jones Day Leads in Supreme Court Arguments With New FacesJohnson & Johnson (J&J) is currently seeking approval for an $11 billion settlement to resolve ongoing litigation concerning its talc-based baby powder, which has been alleged to cause ovarian cancer. This amount is a significant increase from a previous offer of $8.9 billion. J&J's strategy involves a third attempt at a bankruptcy filing, specifically a pre-packaged bankruptcy, which allows for faster processing if they secure enough creditor support—in this case, needing the approval of 75% of the talc plaintiffs.The company proposes to pay $6.48 billion over 25 years to settle ovarian cancer claims, but it has not specified how funds will be divided between existing and future claims. Additionally, J&J has nearly settled all claims regarding mesothelioma believed to be caused by asbestos in the powder. This settlement approach follows multiple failed attempts to use Chapter 11 to manage these lawsuits, which now number almost 60,000.These lawsuits have been a significant factor depressing J&J's stock price, according to analysts. Despite the legal challenges, J&J maintains that its talc products do not cause cancer and asserts that it has marketed its baby powder responsibly for over a century. A recent verdict, however, led to a $45 million payout to a family, implicating J&J and its spinoff Kenvue in the ongoing litigation.The company's persistence in seeking a bankruptcy-based settlement reflects its strategic approach to managing a complex legal challenge that impacts thousands of plaintiffs and could potentially set a precedent in how large corporations handle mass tort liabilities through bankruptcy court.J&J Seeks Backing for $11 Billion Baby Powder Cancer SettlementIn President Joe Biden's Fiscal Year 2025 Budget Proposal, a notable change is the suggestion to tax unrealized gains—value increases in assets not yet converted into cash through a sale. This marks a significant shift from traditional tax frameworks, which typically avoid taxing unrealized gains due to their complexity, potential liquidity issues, and difficulties in implementation.The rationale behind this proposal is to ensure tax fairness by capturing increases in wealth that currently escape taxation. For example, if a billionaire's stock appreciates significantly without being sold, they realize no taxable gain. However, if they borrow against these increased values, they effectively use this appreciation as a means to generate wealth without incurring tax liabilities. This situation presents a loophole where wealth can grow and be leveraged without contributing to the tax base.The FY2025 budget aims to address these disparities by proposing a tax on unrealized gains for very high-net-worth individuals and entities that have not been subject to a tax event in the last 90 years. This approach seeks to broaden the tax base without raising rates, aiming to increase tax revenue from the wealthy without additional burdens on middle and lower-income individuals.This policy shift acknowledges the need to adapt tax strategies to a changing economic environment where traditional taxation methods no longer capture all forms of wealth accumulation. The proposal suggests that a more equitable tax system requires taxing wealth as it grows, even if it is not realized through a sale. By proposing to tax unrealized gains, the administration intends to correct imbalances allowing substantial wealth to accumulate tax-free, signaling a significant potential change in how wealth is taxed in the U.S.Unrealized Gain Tax—A Coming Sea Change in FY2025 Budget Proposal? Get full access to Minimum Competence - Daily Legal News Podcast at www.minimumcomp.com/subscribe

When thinking of everyday personal care, we look towards skincare fit for Asian skin and innovation that does not contain nasties, combining both good clinical derma care and aesthetics. So what are the biggest skincare trends in recent times? And how can one care for their skin amidst climate change? Kesh Gunasinghe, Head of R&D APAC, Kenvue shares more. See omnystudio.com/listener for privacy information.

South Africa's health regulator said on Saturday it is recalling batches of Johnson & Johnson's children's cough syrup after detection of high levels of diethylene glycol. The affected batches were sold in South Africa, Eswatini, Rwanda, Kenya, Tanzania and Nigeria, the statement added. The recall follows a report by the regulator's Nigerian counterpart on Wednesday, which first detected the toxin in a batch of Benylin Paediatric Syrup. Kenya and Nigeria have already issued recalls for the same syrup, which is used in the treatment of hay fever and other allergic conditions affecting the upper respiratory tract. Kenvue, which now owns the Benylin brand after a spin-off from J&J last year, said in a statement that it is conducting its own assessment and working with health authorities to determine a course of action. "A review of our global safety database for the period between product release in May 2021 and up to 11 April 2024 did not identify any serious adverse events for any batch of Benylin Paediatric Syrup," it said. High levels of diethylene glycol in cough syrup has been linked to the deaths of dozens of children in Gambia, Uzbekistan and Cameroon since 2022 in one of the world's worst waves of poisoning from oral medication.

In this episode, HBW Insight's Europe and US editors Tom Gallen and Malcolm Spicer bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago, Kenvue, soon to celebrate its first anniversary as a new company; Sanofi, which has announced it will be exiting the OTC market by divesting its OTC business and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the possible advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.

*Hosted by Radu Palamariu*In this episode, I interviewed Meri Stevens, Chief Operations Officer at Kenvue. Meri shares her vast experience in an industry that constantly demands adaptability and clear strategy and how this led to Kenvue's domination in the market. She briefly explains how strategic divestitures help companies maximize their value by focusing on specific competencies and targeted audiences, providing an insider look into some of the toughest decision-making processes in business.Discover more details here.Follow us on:Instagram: http://bit.ly/2Wba8v7Twitter: http://bit.ly/2WeulzXLinkedin: http://bit.ly/2w9YSQXFacebook: http://bit.ly/2HtryLd

Climate change is already wreaking havoc on the weather and food supplies. But now dermatologists worldwide are blaming it for an uptick in skin issues such as cancer, dermatitis and premature skin ageing. Kesh Gunasinghe, head of R&D Asia Pacific at Kenvue, shares his tips on how to better protect the human body's largest organ. See omnystudio.com/listener for privacy information.

In this episode of Over the Counter, HBW Insight speaks to Paul LaTerra, Director, R&D, Global Hair and Scalp for Kenvue, a New Jersey-based consumer health company that markets skin care brands Neutrogena, Aveeno and Lubriderm. We discuss growth of the beauty-from-within supplements market, how the products complement topical skin care and hair formulas and the growing body of research demonstrating significant skin and hair health benefits.

In this episode of BRAVE COMMERCE, Eric Tarnowski, VP of Connected Commerce at Kenvue, joins hosts Rachel Tipograph and Sarah Hofstetter to offer insights into the complexities of change management and the strategic imperatives of connected commerce in the digital era. The conversation begins with Sarah and Rachel exploring the challenges of change management, highlighting the inherent resistance to change among individuals. They discuss the importance of overcommunication, aligning change with business strategy, incentivizing employees, and fostering transparency to facilitate successful change management. These principles set the stage for Eric Tarnowski's insights into navigating change within Kenvue. Eric elaborates on Kenvue's transition from Johnson & Johnson and the spin-off process, emphasizing the significance of trust, common purpose, shared consciousness, and empowered execution in driving organizational change. Communication, he says, is pivotal to transparency, and alignment with business strategy and in mobilizing teams towards a common goal. As the conversation progresses, Eric traces his journey at Kenvue from technology and data management to his current role as VP of Connected Commerce, noting his focus on digital transformation and e-commerce integration. He provides a detailed overview of Kenvue's approach to connected commerce, emphasizing the convergence of marketing, sales, and technology. He outlines the challenges of orchestrating cross-functional collaboration and the importance of outcome-based handoffs, trust-building, and continuous improvement in driving organizational success. Furthermore, Eric illustrates Kenvue's connected commerce strategy through a case study on a recent product launch. He highlights the coordinated efforts across branding, media, retail, and consumer experience to drive business performance and consumer relevance. Throughout the interview, Eric returns to the consumer-centric approach of Kenvue's connected commerce model, emphasizing the importance of consumer insights, brand positioning, and personalized experiences in driving engagement and loyalty. Key Takeaways: ● Foster transparency to manage resistance to change effectively● Place the consumer at the center of marketing strategies to drive relevance and engagement● Use data and analytics to gain insights, measure outcomes, and drive strategic decision-making Hosted on Acast. See acast.com/privacy for more information.

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Laurin Meyer und Holger Zschäpitz über Erleichterung bei Delivery Hero, stählerne Probleme bei Thyssenkrupp und Nvidias Fahrt auf der Überholspur. Außerdem geht es um Amazon, Alphabet, Microsoft, Cisco, Twilio, Uber, Lyft, Upstart, ProSiebenSat.1, Coca-Cola, Mondelez, McCormick, Hershey, PepsiCo, Kraft Heinz, Novo Nordisk, Nu Holdings, AT&T, Apple, Microsoft, First Advantage Corp., Canadian Pacific, General Electric, Solarwinds, HCA Healthcare, CVS Health, Oracle, Warner Bros. Discovery, Block, Mettler-Toledo, JD, Alibaba, Stellantis, Apple, Five Below, Home Depot, Nike, Salesforce, GoDaddy, Booking, Paramount Global, HP, Dr. Horton, Stoneco, Chevron, Occidental, Sirius XM, Viatris, Kenvue, Johnson&Johnson, Bayer, Goldman Sachs, Invesco Aerospace & Defense Portfolio (WKN: A2JNSR) und SPDR S&P Aerospace & Defense ETF (WKN: A1JYC4) und iShares MSCI Europe Quality Factor (WKN: A12DPM). Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hier findet ihr alle AAA-Bonus-Episoden bei WELT – dazu den AAA-Newsletter und noch weitere WELTplus-Inhalte: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Join our host Evren Ozkaya as he welcomes ⁠Michael Altman⁠, VP of End-to-End US Supply Chain Operations at ⁠Kenvue ⁠for an insightful discussion on managing one of the largest disruptions of supply chain in the Pharma industry. This episode delves into the crucial balance between capital, cost and service/availability, the significance of an end-to-end supply chain view, and strategies for navigating disruptions, highlighted by lessons from the COVID-19 pandemic. Using the backdrop of the Tylenol supply chain disruption story during the early days of pandemic, Michael & Evren build on their recent HBR article “How Kenvue De-risked Its Supply Chain”. Michael shares his extensive experience and strategies for building resilience and optimization of supply chain operations, offering invaluable insights for anyone looking to understand or improve Pharma supply chains in the face of significant disruptions.

Debbie Reynolds, “The Data Diva” talks to Vikram Koppikar, Senior Manager, Privacy - South Asia and Metropolitan Asia,  Kenvue  - Formally Johnson Consumer Health (Mumbai). We discuss challenges faced by multinational corporations in terms of privacy laws and the differences between GDPR and APAC laws. Vikram expresses concern about the contradiction between the express consent and legitimate use provisions in the recent Indian Data Protection Act and suggests that the provision needs to be clarified or made more similar to the legitimate interest concept in GDPR to address these concerns. We discuss fines and penalties for companies that violate privacy regulations, the rights of Indian citizens to sue, and the importance of privacy as a fundamental right.The conversation touches on data localization requirements, limited data transfer mechanisms, and criminal penalties for data protection infractions in Asia, with a suggestion that monetary penalties on corporates may be more effective than criminal punishment. Debbie and Vikram stress the importance of ethical and legal processing and utilization of personal information for both individual and corporate benefit. They agree that companies must understand that data belongs to people and that privacy is a fundamental right.Vikram shares his hope for a society that realizes the power of personal information and the benefits it can bring to citizens, and Debbie highlights the importance of empowering people to understand their rights. They also discuss the impact of data protection regulations on companies, emphasizing the need for a roadmap to know what is expected of them when doing business in different regions.Support the show

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Laurin Meyer über Zinsfantasien bei Vonovia, einen guten Wurf von Foot Locker und Warren Buffetts neueste Investition. Außerdem geht es um Patrizia, Siemens Energy, Zalando, Occidental Petroleum, Berkshire Hathaway, Moderna, OMV, Covestro, BASF, ARM, Kenvue, Birkenstock, Schott Pharma, ThyssenKrupp Nucera, Ionos, Lindt&Sprüngli, Calida, Swatch, Carnival Corporation, Accor, LVMH, Sixt und Tesla. Wir freuen uns über Feedback an aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hier findet ihr alle AAA-Bonus-Episoden bei WELT – dazu den AAA-Newsletter und noch weitere WELTplus-Inhalte: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

The Daily Business and Finance Show - Friday, 8 December 2023 We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days! Please click here for more info: Subscribe to Seeking Alpha Premium News Today's headlines: Amazon to stop accepting Venmo as a payment option from January 10, 2024 Broadcom increases dividend by ~14% to $5.25 Broadcom slips despite strong 2024 guidance, Q4 results AMD's AI event brings flurry of positive reactions; others are neutral Dow, S&P halt three-day losing streak, Nasdaq adds +1% on Google, AMD boost Google's Gemini launch represents 'significant innovation' in Gen AI race: JPM Philip Morris declares $1.30 dividend Canada to impose oil and gas emissions cap, in goal to reach net zero by 2050 Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update) Explanations from OpenAI ChatGPT API with proprietary prompts. This podcast provides information only and should not be construed as financial or business advice. This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

Joahne Carter, commercial leader of oral care at Kenvue, marketer of Listerine, talks about why the brand addressed the lack of Black professionals in dentistry.

Volunteering helps communities and organizations. But it also helps the volunteers who donate their time and skills. In a roundtable discussion, guests share how they started volunteering, how it has affected their careers and helped them grow as project professionals, the different ways they have taught project management skills to make initiatives run more efficiently and their advice to others looking to start their own community volunteering journey.Our guests include Lebogang Ngoato, PMP, program manager, Absa Group, Johannesburg; Priya Patra, PMP, director, Capgemini, Mumbai, India; and Silvana Tovar, international trade coordinator, Kenvue, São Paulo.Key themes[01:52] Why start volunteering? Three professionals share their stories[06:57] How volunteering can boost project professionals' careers[11:25] The value of sharing your project management skills[14:07] How volunteering can help professionals upskill[18:20] Keeping volunteers motivated to work on outside projects[20:44] Advice for potential volunteers: share your knowledge, be honest about your availability and keep an open mind

In this episode, I sit down with Sarah Lachance, Director of Identity and Access Management at Kenvue, about cyber security, coming into tech as an outsider, and how you can never take people out of the equation. 

How does one launch a brand in a new country? How does one build relevance in a new market? What are the potential roadblocks?In today's episode of Dig In, Jess dives into these questions through through an engaging and insightful conversation with Sarah Dibblee, Brand Team Lead at Kenvue for Zarbee's. Having recently entered the Canadian market this past summer, Jess and Sarah explore the intricacies involved in launching Zarbee's, a children's medicine company, in Canada.Join us to discover: Zarbee's approach to launching their brand in a new country Crafting a comprehensive 360-degree digital communications plan The importance of Social Listening as a source for valuable insights --------------Subscribe to our podcast on your favourite platforms: Apple Podcasts Spotify Google Podcasts Amazon Music Other platforms Have ideas for our next episodes? Connect with Meagan, our Senior Marketing Director on LinkedIn.Enjoying our podcast? Leave us a review!Connect with us here: LinkedIn Website

Johnson & Johnson (J&J) is signing off on a new logo. The healthcare giant said that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices. Johnson & Johnson itself narrowed its focus to pharmaceuticals and medical devices. The new look, which includes a different shade of red, aims to recognize J&J's shift into a “pure play healthcare company,” said Vanessa Broadhurst, a company executive vice president. The signature logo was “one of the longest-used company emblems in the world,” J&J declared in a 2017 website post. But it started showing its age in an era of texting and emojis. Many children no longer learn to write cursive in school, noted marketing consultant Laura Ries. People may recognize the signature, but they weren't necessarily reading it, she said. The new logo, she said, is easier to process. “Because it's easier, it almost even draws your attention to it,” said Ries, who wasn't involved in the logo change. Ries also noted people likely identified the script logo more with the Kenvue products they see on drugstore shelves, such as Band-Aids, Listerine, and Tylenol. “Everyone washed their baby with Johnson & Johnson baby shampoo,” she said. A Kenvue spokesperson said the J&J branding on products like Band-Aids will gradually be removed. The signature logo also could be found on bottles of the company's now-discontinued talcum-based baby powder, which generated lawsuits alleging that it caused cancer. J&J has insisted that the powder was safe. The consumer business helped J&J become the world's biggest healthcare products maker, with annual sales topping $90 billion. But, its pharmaceutical and medical device divisions had easily surpassed it in size when the spinoff was announced in late 2021. New Brunswick, New Jersey-based J&J also said that it will relabel its Janssen pharmaceutical business Johnson & Johnson Innovative Medicine. Its medical devices and technology segment will be called Johnson & Johnson MedTech. This article was provided by The Associated Press.

In the second part of HBW Insight's exclusive interview with OTC industry veteran Birgit Schuhbauer, we discuss the trends that will shape the future of consumer health. Drawing on her extensive experience in consumer health, most recently as global vice president of J&J's Self Care franchise and president of the AESGP,Schuhbauer gives her views on: consumer shifts towards self-care and prevention, digitalisation and e-commerce, supply chain resilience and sustainability. Schuhbauer also gives an insider perspective on moves by companies like Kenvue and Haleon to spin out as independent OTC players, and the implications for Rx-to-OTC switch, for example.

Masimo this week announced the launch of its Stork home baby monitoring system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and how it fits in with the flagship products already with the company. Home hemodialysis is on the rise. Fresenius Medical Care recently received FDA 510(k) clearance for its Versi HD with GuideMe software for its chronic home hemodialysis system. Find out when the technology will become available and how executives envision it for use in the home in today's episode. Diabetes care devices are consistently innovating, and Welldoc's continuous glucose monitoring is having an exceptional month. Just a week after it received its tenth FDA clearance, Welldoc has received its 11th FDA clearance for its BlueStar digital diabetes management platform. Whooley details what makes this clearance unique and what the clearance allows the company to do. Johnson & Johnson is placing more focus on its MedTech and Pharmaceutical division by splitting off its Kenvue consumer health business. The Fast Five hosts share the results of the split off and what executives are saying. Renal denervation is a hot topic in medtech right now with varying opinions on its success. This week, an FDA panel voted unanimously in favor of the safety and efficacy of Recor Medical's Paradise ultrasound renal denervation system. Find out what data was included in the PMA submission and what executives are saying. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

The Daily Business and Finance Show - Monday, 21 August 2023 We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days! Please click here for more info: Subscribe to Seeking Alpha Premium News Today's headlines: Medical Properties Trust slashes dividend to strengthen balance sheet Nvidia pops as Wall Street hikes price targets for 'Godfather of AI' Google mulls offloading another office campus in California - report ArcelorMittal may have been first to show interest in U.S. Steel; may bid $38 - reports Energy Transfer makes case for new Lake Charles LNG export license Treasury yields climb with the 10Y topping a 52-week high and 2Y retaking 5% Johnson & Johnson, Kenvue share exchange offer oversubscribed Intel to cut 140 jobs at California sites Explanations from OpenAI ChatGPT API with proprietary prompts. This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

U.S. ECM activity showed positive signs in the first half of 2023 after a two-year decline thanks to improving market conditions. This episode examines factors driving the uptick in recent activity, evaluates whether recent IPOs by Kenvue, Cava Group and Oddity suggest a broader market resurgence, and explores the influencing factors for ECM deals leading into early 2024. Tune in for valuable perspectives on these ECM trends. Dealcast is presented by Mergermarket and SS&C Intralinks. Dealmakers, download the SS&C Intralinks Deal Flow Predictor for Q3 2023 to get an exclusive preview of global and regional M&A activity in the next six months: https://www.intralinks.com/deal-flow-predictor

A project that doesn't align with an enterprise's objectives will never be considered a success. But project managers with a strong understanding of the business landscape and their organization's goals can execute projects that drive their companies' priorities—and deliver real benefits. We discuss this with: Ayobamiji Iyiola, PMI-ACP, PMP, senior IT project manager, First Bank of Nigeria, Lagos: Iyiola discusses the processes he uses to determine his organization's goals, how he created success measures so a project drove the bank's objectives for increased exposure and customer acquisition, how he manages change on projects when organizational priorities shift and his advice to project professionals on the importance of business acumen.Omar Picone Chiodo, PMP, PgMP, PfMP, senior portfolio management office director, Kenvue, Zug, Switzerland: Picone Chiodo discusses ways project professionals can learn their enterprise's strategic objectives, how to create processes to better align portfolios with an organization's goals, ways to engage with stakeholders to create success measures that everyone sticks to, and why clear and concise communication with leaders can have a big effect on what happens to a portfolio when an organization's goals change. Key themes[01:50] Identifying an organization's objectives—and using projects to achieve them[05:13] Creating project success measures to drive a bank's acquisition goals[10:02] Managing change when a company's priorities shift[13:50] Communicating an organization's goals through onboarding sessions, knowledge libraries and talks with leadership[15:11] Developing processes to align portfolios with an enterprise's objectives[16:39] How to keep stakeholders informed—and in line with the same measures of success

Summer edition! Tech stocks have been sizzling. Mike is up huge on tech, what stock does he buy to diversify? The debate over Starbucks in grocery stores gets intense. Visa or Mastercard…or both. Final thoughts with HBO's “Succession.” And so much more stock talk in this hour plus episode.

Fear of medications and their side effects is a major reason why many people don't take their arthritis meds as prescribed, but it's not the only one. Learn more about some reasons people skip doses or don't take their meds, why that's a bad idea, and hear ways to feel more confident and able to stick with your meds. This episode was brought to you in part by AbbVie, Bristol Myers Squibb, Janssen and Kenvue. Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://bit.ly/LiveYes_Ep84 We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing podcast@arthritis.org. Special Guest: Elizabeth Salt, PhD, APRN .

Philips recently announced Q2 results and an update on the ongoing DOJ talks and layoffs. Industry analysts may discuss Philips' forward-looking plans to mitigate order intake volatility and maintain a competitive edge in the medical device market. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the quarterly results and what the current status of the ongoing consent decree. The launch of Biosense Webster's AFib mapping catheter signifies J&J's commitment to advancing cardiac ablation technologies for atrial fibrillation patients. Hear how the technology works, how it could benefit clinicians and what doctors and executives think about it. This week, Baxter announced it launched the PerClot absorbable hemostatic powder in the U.S. Whooley shares the technology behind PerClor and how it enhances clinicians' abilities to optimize patient care. Inspire Medical Systems' selection of a former Medtronic executive as the new chief strategy officer underscores the ongoing talent mobility within the medical device industry. Find out who joins the respiratory therapy company's C-suite and what their career history has been to support the new role. J&J's decision to consider a split-off of Kenvue highlights the company's ongoing efforts to streamline its business portfolio and focus on core MedTech and pharmaceutical segments. Whooley and Kirsh discuss the details of the planned exchange offer, what shareholders could receive and what percentage of outstanding shares are up for grabs. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

The Daily Business and Finance Show - Monday, 24 July 2023 We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days! Please click here for more info: Subscribe to Seeking Alpha Premium News Today's headlines: Johnson & Johnson launches Kenvue exchange offer Rithm Capital to acquire Sculptor Capital for $639M 'Barbie' and 'Oppenheimer' give jolt to summer box office Spotify sinks even as it announces increase in US premium prices (updated) Stock valuations are justified, even in the face of rising rates - Goldman Ares Capital faces hit to Q2 earnings as credit conditions look set to remain tight Nasdaq, S&P, Dow kick off eventful week with gains ahead of earnings deluge, Fed meet Crown Castle slashes 15% jobs, to take $120M restructuring charge - filing Explanations from OpenAI ChatGPT API with proprietary prompts. This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices

This is our last episode of Season 3, and it is a jam-packed show. The week's news involved the earnings from both $JNJ and $KVEU. EDGI gave his opinion on both and explained the upcoming Split off and what this means. This is completely different than the standard spin-off that most investors are used to.  The main topic centered around our Q2 portfolio reviews which have seen some impressive results year over year. We rounded up the main topic with our European flavor by looking at the earning of ABB, Novartis, Evolution AB, and Assa Abloy.   We finished off the show by answering questions from our community. Hope you enjoy it. Tickers mentioned are SIX:ABBN, SIX:NOVN, STO:EVO, ASSA.B , STO:CIBUS, UKW

Elon Musk optimistic about economy, Tesla's operating income to shrink, Billy Sarracino appointed CEO of Turvo, Colorado Clean Energy Fund and NEIF partner for LED lighting projects, Kenvue forecasts full-year profit above estimates, Freeport-McMoRan reports 60% profit decrease, TSMC delays production at Arizona chip plant, Netflix shows renewed subscriber growth, Coca-Cola CEO leads sustainability efforts, Senate Democrats pledge nonintervention in UPS-Teamster dispute, Amazon introduces palm-scanning payment system.

In the developing post-pandemic landscape, the discussion of a possible recession has been the latest ongoing hot topic, leaving businesses in a difficult position for decision-making. Today's guest is sharing his expansive career knowledge to inform businesses about the reality of the current market. We're sitting down with my only two-time guest, Gregg Nabhan. If you tuned in to the first episode with Gregg, you'll remember that he's Chairman of America's Equity Capital Markets for Bank of America, as well as Managing Director of the Consumer and Retail Team.Gregg is responsible for the origination, IPO valuation, structuring, book-building, price discovery, allocation trading, and aftermarket performance of the equity transactions. He has 35-plus years of experience on Wall Street, and during the last 20 of those years, Gregg has led over 400 transactions raising over 265 billion dollars for companies around the world including 115 IPOs.Prior to joining B of A in June of 2008, Gregg worked at Morgan Stanley for 13 years where he was an MD in their equity capital markets group. On this week's episode, we talked about the reality of the current economic market. Highlights: A brief overview of the current economic market (2:44) How Gregg sees the current economic landscape, and its rate of potential risk (3:40) Gregg breaks down how to understand the perspective of market fluctuation and trends (5:02) Current events affecting the economy, and economist predictions (7:16) Understanding the context of the current IPO market (8:38) Areas of focus for management teams maneuvering the economic climate (10:24) Industries of focus for investors looking to put their money to work (12:42) Analyzing past IPO market trends and predicting the potential future of the space (13:53) What made an investment like Kenvue so successful for investors? (15:37) Insight on dividends and buybacks (17:55) Techniques that issuers are using to navigate the current market (18:55) Adjusting focus from daily changes to long-term planning (21:55) Gregg's biggest piece of advice to listeners and investors (23:34) Links:ICR TwitterICR LinkedInICR WebsiteGregg's first WTTA episodeBank of America on LinkedInBank of America WebsiteFeedback:If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Lena Zimmermann und Laurin Meyer über entspannte Großbanken in den USA, volle Lager bei Nike und eine Kursrakete aus der Bio-Pharmazie. Außerdem geht es um Morgan Stanley, Goldman Sachs, Wells Fargo, Deutsche Bank, Micron, Infineon, Aixtron, H&M, Sigilon, Eli Lilly, Renault, Porsche, BMW, Volkswagen, Mercedes-Benz, Nexchip Semiconductor, SMEC, CSI Solar, Kenvue, Cava, Ionos, Virgin Galactic, Mynaric, OHB, Maxar Technologies, SES, Astra Space, Airbus, Boeing, Leonardo, Thales, Lockheed Martin, VanEck Space Innovators ETF (WKN: A3DP9J) und HANetf Procure Space ETF (WKN: A3CUJ9). Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über die rasante KI-Mania, die Suche nach der nächsten Nvidia und eine Hochzeit mit Kampfansage. Außerdem geht es um Infineon, Fresenius, Nvidia, Marvell Technology, United Airlines, Delta Airlines, American Airlines Group, Coinbase, Kenvue, Johnson&Johnson, Ford, Tesla, Daimler Truck, Toyota, C3.AI, Palantir, Upstart, Soundhound AI, Apple, Microsoft, Saudi Aramco, Amazon, Alphabet, Berkshire Hathaway, LVMH, ARK Innovation (WKN: A14Y8H), Meta, Novo Nordisk, Eli Lilly, Uber, Tencent, Alibaba, TSMC, Visa, Mastercard, Paypal, SAP, Siemens, Deutsche Telekom, United Health, Coca Cola und iShares Dow Jones Global Titans 50, WKN: 628938).

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über haussierende China-Papiere, eine drückende Turnschuh-Aktie und die großen Zinsgewinner an der Wall Street. Außerdem geht es um Home Depot, AMD, Alphabet, Amazon, Nvidia, Microsoft, Hornbach Holding, JD.com, Baidu, Siemens Energy, SMA Solar, Encavis, Nordex, VW, Porsche AG, Mercedes-Benz, Zalando, Adidas, Hellofresh, On Holding, Deutsche Telekom, Telecom Italia, Vodafone, Qualtrics, Pfizer, Viatris, Kenvue, Apple, Ford, Intel, GM, Cisco, Coca Cola, Johnson&Johnson, Tesla, United Airlines, First Solar, DXC Technology, Alaska Air, Wynn Ressort, Southwest Airlines, AirBnB, Servicenow, AES, PG&E, Live Nations, Royal Carribean, Expedia, American Airlines, Booking

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über sonnige Aussichten für First Solar, eine wegweisende Woche für China und eine neue Twitter-Chefin. Außerdem geht es um Tesla, AirBnB, The York Water Company, Stanley Black & Decker, Procter & Gamble Colgate-Palmolive, PPG Industries, Church & Dwight, Exxon Mobil, Coca Cola, Trane Technologies, Johnson&Johnson, Kenvue, Haleon, GSK, SPDR MSCI World Consumer Staples (WKN: A2AGZ0), XTrackers MSCI Europe Consumer Staples ESG (DBX1FB) und First Trust IPOX Europe Equity Opportunities (WKN A3CPHY). Und hier könnt für AAA beim Deutschen Podcastpreis abstimmen: https://www.deutscher-podcastpreis.de/podcasts/alles-auf-aktien/

Den Podcast als Newsletter kriegen? Komm in die Gruppe! Airbnb hat schwache Prognose. USA hat schwache Inflation. Siemens Healthineers hat schwache Übernahme. Ansonsten verstopfen Meme-Coins die Bitcoin-Blockchain und bei Upstart läuft's wieder. Neutrogena. Listerine. Carefree. All diese Marken gehören zu Kenvue (WKN: A3EEHU). Kenvue gehörte lange zu Johnson & Johnson, aber ist seit letzter Woche selbst an der Börse. Und zwar auf höchstem DAX-Niveau. Der Bitcoin halbiert sich. Alle vier Jahre. Investoren lieben es. Diesen Podcast vom 11.05.2023, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung. Learn more about your ad choices. Visit megaphone.fm/adchoices

Absolute-value investor Brian Frank of the Frank Value Fund says that with cash now paying close to 5 percent, it's 'gotten a lot easier to go to cash,' but it also has raised the bar on stocks and for how investors should set their expectations. 'If you don't think you're going to be making more than 5 percent on a stock,' Frank says in the Market Call, 'why are you buying it if cash is paying you [5 percent] now?' Also on the show, Lewis Black, chief executive officer at Almonty Industries, talks about the market for tungsten and how the metal has the potential to be the cause of tough economic conditions and geopolitical football; David Trainer of New Constructs puts Kenvue -- the spin-off of Johnson and Johnson consumer brands -- in the Danger Zone in its first few days after going IPO, and Chuck answers a listener's question that goes to the heart of Brian Frank's discussion on going to cash, about whether cash returns are so good right now that a nervous investor might use bank accounts to ride out whatever the market dishes out next.

8 mai 2023 | L'essentiel des nouvelles économiques, technologiques et financières [texte non corrigé pour fins de publication]Le prix médian des maisons unifamiliales vendues au Québec a remonté pour un troisième mois consécutif. Il est passé de 375 000 $ en janvier à 425 000 $ en avril, selon l'Association professionnelle des courtiers immobiliers du Québec. Malgré cette remontée, le marché n'a pas repris sa vitesse de l'an dernier. Le nombre de transactions enregistrées en avril a été de 28% plus bas qu'en avril de l'an dernier. Selon Statistiques Canada, il s'est créé, en solde net, un peu plus de 40 000 emplois au Canada en avril.Le rythme de création d'emploi s'est accéléré pour un huitième mois consécutif, ce qui ne s'était pas produit depuis 2017.Selon Warren Buffett, l'inquiétude des Américains envers leur secteur bancaire n'est pas fondée.C'est ce qu'a dit en substance samedi le légendaire investisseur lors de l'assemblée générale annuelle du conglomérat qu'il dirige, Berkshire Hathaway. Il commentait la crise qui secoue le secteur après les faillites successives de 3 banques ces dernières semaines.Selon Buffett, le problème est que les clients des banques ne comprennent pas que leurs dépôts sont garantis, non seulement jusqu'à 250 000 $US par une agence gouvernementale, la FDIC, mais même au-delà, parce que Washington ne permettra jamais que les clients de banques américaines perdent leurs dépôts.Le géant pharmaceutique américain Johnson & Johnson a introduit en bourse sa nouvelle filiale Kenvue, dans laquelle elle a transféré ses marques de consommation courante liées à l'hygiène et à la santé, comme Band-Aid, Tylenol et Listerine. Avec une capitalisation boursière supérieure à 41 milliards $US le jour de son entrée en bourse, Kenvue est devenue la plus importante introduction à la Bourse de New York depuis 2021. Comme chaque lundi, InfoBref vous fait découvrir une jeune entreprise québécoise innovante.Aujourd'hui une startup de Montréal, Azimut Médical:En vieillissant, les os des personnes âgées se fragilisent, et peuvent se briser plus facilement en cas de chute. Pour une personne ainée, une fracture est souvent lourde de conséquences: il y a des risques que la personne ne s'en remette jamais complètement.Pour protéger les ainés contre ces risques, Azimut Médical a conçu un sous-vêtement qui peut détecter une chute et se gonfler automatiquement pour amortir le choc.Pour en savoir plus sur ce produit, lisez, en 2 minutes, le portrait d'Azimut Médical à InfoBref.com.--- Détails sur ces nouvelles et d'autres nouvelles: https://infobref.com S'abonner aux infolettres gratuites d'InfoBref: https://infobref.com/infolettres Écouter les balados d'InfoBref: https://infobref.com/audio [Découvrez Actualités InfoBref, un balado quotidien des principales nouvelles générales, parfaitement complémentaire d'InfoBref Affaires] Voir notre épisode hebdo «à retenir cette semaine»: https://www.youtube.com/@infobref Commentaires et suggestions à l'animateur Patrick Pierra, ou pour commanditer nos balados: editeur@infobref.com Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

In today's show, we're discussing first-quarter earnings results from some of our favorite dividend growth stocks. No surprise, but Microsoft and Novo-Nordisk just had to be in there! Tickers discussed: $WBD, $JNJ, $LEG, $CCOI, $SPG, $PEP, $AAPL, $MSFT, $TROW, $EMR, $RACE, $SHELL, $NOVN, $TYO:7974, $CVS Interested in buying a nice t-shirt or hoodie with one of your favorite quotes from the dividend talk podcast? Then check out or Dividend Talk shop: https://dividendtalk.myspreadshop.ie/ Join us on Facebook: https://www.facebook.com/groups/dividendtalk

Get ready for the juiciest news in tech and finance on this week's episode of The Liquidity Event! We're talking about everything from JPMorgan's Silicon Valley takeover to a shocking report that companies are cheating the H-1B visa lottery. Plus, we'll dish on the gender earnings gap, inflation, and why a 37-year-old making over $200K is ready to break up with New York City. And don't miss our updates on J&J's billion-dollar spinoff Kenvue, AI's impact on the job market, and the wild story of the First Republic Bank failure. So tune in, turn up, and let's get into The Liquidity Event!   Links Companies Are Colluding to Cheat H-1B Visa Lottery, U.S. Says The Writers' Strike, DVDs and the Death of Free Money JPMorgan's Silicon Valley Moment ‘Godfather of AI' quits Google with regrets and fears about his life's work Gender Earnings Gap Shrinking at Record Rate, Pew Says A 37-year-old making over $200K is rethinking her location after her rent shot up to $5,500: ‘I'm in a toxic relationship with New York City' Apple's New Savings Account Draws Nearly $1 Billion In Deposits In First Four Days Ranking Individual Income Taxes on the 2023 State Business Tax Climate Index M&T: Super High Quality Regional Bank Trading At Bargain 7.5x EarningsNew York and California lost over $90 billion in income to low-tax states during Covid Why Is Inflation So Sticky? It Could Be Corporate Profits J&J's $43 Billion Spinoff Brings Band-Aid, Tylenol to Hurting IPO Market J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market J&J's Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021 Kenvue – J&J's consumer health spinoff – signs on for Summit HQ US IPO Weekly Recap: J&J Spin-Off Kenvue Launches Billion-Dollar Deal In A 1 IPO Week Murphy, N.J. officials thrilled to have J&J's billion-dollar spinoff put its HQ in Summit ChatGPT Will See You Now: Doctors Using AI to Answer Patient Questions AI Disruption Deepens With Chegg Plunge, IBM Hiring Halt, Samsung Chatbot Ban ChatGPT Threat Sparks 38% Selloff in Homework-Help Firm Chegg IBM to Pause Hiring for Jobs That AI Could Do What's Going On With First Republic Bank? Jamie Dimon Wins Again in First Republic Bank Deal First Republic Bank Is Seized, Sold to JPMorgan in Second-Largest U.S. Bank Failure   Want to know more about working with BrooklynFI, contact us here 

Den Podcast als Newsletter kriegen? Komm in die Gruppe! Was war da los? Rund 20% abgeschmiert sind: New Work, PacWest, Western Alliance, First Horizon & Paramount. Mehr als 20% gestiegen sind: Shopify, Kenvue & Arconic. 0,25 Prozentpunkte gestiegen ist der Leitzins in Europa, 2% gestiegen sind iPhone-Umsätze. Mit FOMO viel Geld verdienen. Soho House (WKN: A3CUW0) macht's möglich (aber eben nicht für alle). Alle fliegen zum Mond. China-Aktien schmieren ab. Was steckt hinter dem stillen Crash? Diesen Podcast vom 05.05.2023, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung. Learn more about your ad choices. Visit megaphone.fm/adchoices

One day after the Fed's tenth consecutive rate hike, Carl Quintanilla, Jim Cramer and David Faber discussed another rough session for regional banks. Shares of First Horizon plunged after itsdeal to be acquired by TD Bank was scrapped. PacWest also tumbled -- the bank is mulling strategicoptions including a possible sale. Hear what Jim had to say about "excellent banks" that are getting crushed. Also in focus: What to expect from Apple's after-the-bell earnings, Paramount posts a Q1 miss and slashes its dividend,Qualcomm's weaker-than-expected guidance overshadows a quarterly beat, The CEO of J&J consumer health spin-off Kenvue visited Post 9 to discuss his company going public with the biggest U.S. IPO since November 2021. Squawk on the Street Disclaimer

Sigma USA; La Comer; Mercado Libre; Merama en Chile; importaciones en EUA; Lazard; de Suiza a Monterrey; Kenvue; Flexport y Shopify; Maserati y sus eléctricos; quarterbacks; bolsas fakePrueba Whitepaper 30 días gratis http://whitepaper.com.mx/30day

Investing's biggest weekend is almost here. (00:21) Ricky Mulvey and Asit Sharma discuss:  - Johnson & Johnson's spin-off of its consumer health company, Kenvue.  - If Darden Restaurants is getting a good deal on its acquisition of Ruth's Hospitality Group.  - Yum! Brands quarter, and what it says about the global economy. (12:42) Deidre Woollard and Matt Frankel look ahead to Berkshire Hathaway's annual meeting, taking place this weekend.   Companies discussed: JNJ, KVUE, PG, RUTH, DRI, YUM, BRK.A, BRK.B, RDFN, OXY, CVX, AAPL  Host: Ricky Mulvey  Guests: Asit Sharma, Deidre Woollard, Matt Frankel  Engineer: Dan Boyd

Like many in our industry, John started investing (studying businesses and valuing stocks) in college so he's been analyzing businesses and following markets for almost 25 years. John graduated Phi Beta Kappa and Magna Cum Laude from the University of Richmond and graduated with his MBA as part of the Beta Gamma Sigma International Honors Society from Tulane University. John published a book on Investing titled "A Manual on Common Stock Investing" in 2013. For the past 9 years John has been the Senior Analyst, Portfolio Lead, and the Head of Investor Training and Development at The Motley Fool. He recently resigned from the Motley Fool so he could focus on joining a new team at an institutional value firm as a senior analyst. We talked about a handful of John's favorite businesses and stocks including BRK, O'Reilly Automotive, Nextera Energy, CarMax, and Domino's. We also talked about the private market alternative asset managers via Blackstone, KKR and tried to dispel the myths around taking marks, and the opportunities for the Alt firms as prices get dislocated and dry powder gets put to work at attractive prices. We also talk about John liking energy and banks as sentiment has turned sour. We both like to buy diamonds (great businesses) in the dumpster (hated and with low expectations). We also talk about the JNJ spin-off of its consumer products brand, now called Kenvue. Great talk, I think you'll enjoy it. Follow John on Twitter @JRogrow For more information on the Brands Fund and investing in the worlds leading brands, please go to: https://www.globalbrandsmatter.com/dynamic-portfolio

Even leek de besmettelijke onrust onder Amerikaanse banken te zijn weggeëbd. Maar de bankenonrust waait niet vanzelf over. Want na Silicon Valley Bank en Signature Bank valt er voor de derde keer in korte tijd een Amerikaanse bank om. Laatste in de rij is First Republic. Welke bank(en) volgen hierna?  Beleggers kunnen uitkijken naar twee mega-beursgangen. Allebei in Amerika en allebei moeten ze miljarden opleveren. Waarom kondigen deze bedrijven juist nú - in dit gure aandelenklimaat - hun beursgang aan?  Tot slot krijg je een vooruitblik op de beursdag van morgen.  See omnystudio.com/listener for privacy information.

Even leek de besmettelijke onrust onder Amerikaanse banken te zijn weggeëbd. Maar de bankenonrust waait niet vanzelf over. Want na Silicon Valley Bank en Signature Bank valt er voor de derde keer in korte tijd een Amerikaanse bank om. Laatste in de rij is First Republic. Welke bank(en) volgen hierna?  Beleggers kunnen uitkijken naar twee mega-beursgangen. Allebei in Amerika en allebei moeten ze miljarden opleveren. Waarom kondigen deze bedrijven juist nú - in dit gure aandelenklimaat - hun beursgang aan?  Tot slot krijg je een vooruitblik op de beursdag van morgen.  See omnystudio.com/listener for privacy information.

Netflix is stepping into the gaming world, Hurricane Ian is causing massive amounts of loss, and Apple Music is the new sponsor of the Super Bowl. These stories & more here on This Week in Finance. September 22 - September 29 #hurricaneian #netflix #chipotle ----- 00:00 Intro 00:30 Netflix opens gaming studio 03:27 Google cuts the fun 05:03 Apple cuts production & sponsors halftime show 08:52 Amazon releases new products 11:52 Chips are becoming automated 14:45 Hurricane Ian 17:02 Student loan relief 18:25 JNJ announces Kenvue 18:50 Outro ----- Netflix: https://www.cnbc.com/2022/09/26/netflix-opening-video-game-studio-in-finland.html Google: https://www.cnbc.com/2022/09/23/google-ceo-pichai-fields-questions-on-cost-cuts-at-all-hands-meeting-.html Apple Superbowl: https://www.cnbc.com/2022/09/23/apple-will-sponsor-super-bowl-halftime-show-starting-in-february.html Apple Production: https://www.cnbc.com/2022/09/28/apple-stock-dips-on-report-the-company-bails-on-plans-to-boost-new-iphone-production.html Amazon: https://www.cnbc.com/2022/09/28/live-amazon-announces-new-echos-fire-tv-and-more-gadgets.html Chipotle: https://www.cnbc.com/2022/09/27/chipotle-mexican-grill-will-test-robotic-tortilla-chip-maker-.html Hurricane Ian: https://www.nbcnews.com/news/us-news/live-blog/hurricane-ian-live-updates-rcna49927 Hurricane Industries: https://twitter.com/finfriendsYT/status/1575112770319962113 Student Loans: https://www.cnbc.com/2022/09/29/some-federal-student-loan-borrowers-cannot-consolidate-for-forgiveness.html JNJ: https://www.jnj.com/johnson-johnson-announces-kenvue-as-the-name-for-planned-new-consumer-health-company ----- Website- https://jemi.so/financialfriends